La Quaglia Michael P, Kushner Brian H, Su Wendy, Heller Glenn, Kramer Kim, Abramson Sara, Rosen Nancy, Wolden Suzanne, Cheung Nai-Kong V
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
J Pediatr Surg. 2004 Mar;39(3):412-7; discussion 412-7. doi: 10.1016/j.jpedsurg.2003.11.028.
BACKGROUND/PURPOSE: Gross total resection of the primary tumor in treatment of high-risk neuroblastoma remains controversial. Furthermore, there are few reports of the effect of primary tumor resection on local control as opposed to overall survival. The authors reviewed their institutional experience to assess the effect of primary tumor resection on local control and overall survival.
A total of 141 patients were treated on protocol between November 1, 1979 and June 25, 2002 and are the subject of this report. Gross total resection was assessed by review of operative notes, postoperative computerized axial tomograms, and postoperative meta-iodobenzyl guanidine (MIBG)1 scans when available.
The median age was 3.3 years, and all patients were International Neuroblastoma Staging System (INSS) stage 4 with 79% having metastases to cortical bone. The primary site was the adrenal gland in 74%, the central abdominal compartment in 13%, the posterior mediastinum in 7%, and other sites in 6%. Gross total resection was accomplished in 103 (73%) but was more than 90% for the last 3 protocols. Five kidneys were lost overall. The probability of local progression was 50% in unresected patients compared with 10% in patients undergoing gross total resection (P <.01). Overall survival rate in resected patients was 50% compared with 11% in unresected patients (P <.01).
Our data indicate that local control and overall survival rate are correlated with gross total resection of the primary tumor in high-risk neuroblastoma. Gross total resection should be part of the management of stage 4 neuroblastoma in patients greater than 1 year of age.
背景/目的:在高危神经母细胞瘤的治疗中,对原发肿瘤进行根治性全切除仍存在争议。此外,与总生存率相比,关于原发肿瘤切除对局部控制效果的报道较少。作者回顾了他们机构的经验,以评估原发肿瘤切除对局部控制和总生存率的影响。
1979年11月1日至2002年6月25日期间,共有141例患者按照方案接受治疗,为本报告的研究对象。通过查阅手术记录、术后计算机断层扫描以及术后可用的间碘苄胍(MIBG)扫描来评估根治性全切除情况。
中位年龄为3.3岁,所有患者均为国际神经母细胞瘤分期系统(INSS)4期,79%有皮质骨转移。原发部位肾上腺占74%,中腹部占13%,后纵隔占7%,其他部位占6%。103例(73%)实现了根治性全切除,但在最后3个方案中超过90%。总体共损失了5个肾脏。未切除患者的局部进展概率为50%,而接受根治性全切除的患者为10%(P<.01)。切除患者的总生存率为50%,未切除患者为11%(P<.01)。
我们的数据表明,在高危神经母细胞瘤中,局部控制和总生存率与原发肿瘤的根治性全切除相关。对于1岁以上的4期神经母细胞瘤患者,根治性全切除应作为治疗的一部分。